Status:
COMPLETED
SMART-IBD App Trial
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Conditions:
Inflammatory Bowel Diseases
IBD
Eligibility:
All Genders
13-17 years
Phase:
NA
Brief Summary
The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will co...
Eligibility Criteria
Inclusion
- Patient diagnosed with Crohn's disease, ulcerative colitis, or indeterminate colitis (collectively IBD)
- Prescribed at least one medication used to treat IBD, regardless of route of administration
- Access to internet or wi-fi or data plan and access to smartphone
- English fluency for patient and clinician
Exclusion
- Diagnosis of pervasive developmental disorder in patient or caregiver as determined by medical chart review
- Diagnosis of serious mental illness (e.g., schizophrenia) in patient or caregiver as determined by medical chart review
Key Trial Info
Start Date :
December 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 28 2023
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06023667
Start Date
December 14 2022
End Date
December 28 2023
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229